212 related articles for article (PubMed ID: 35802025)
1. FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits.
Tsai JW; Cejas P; Wang DK; Patel S; Wu DW; Arounleut P; Wei X; Zhou N; Syamala S; Dubois FPB; Crane A; Pelton K; Vogelzang J; Sousa C; Baguette A; Chen X; Condurat AL; Dixon-Clarke SE; Zhou KN; Lu SD; Gonzalez EM; Chacon MS; Digiacomo JJ; Kumbhani R; Novikov D; Hunter J; Tsoli M; Ziegler DS; Dirksen U; Jager N; Balasubramanian GP; Kramm CM; Nathrath M; Bielack S; Baker SJ; Zhang J; McFarland JM; Getz G; Aguet F; Jabado N; Witt O; Pfister SM; Ligon KL; Hovestadt V; Kleinman CL; Long H; Jones DTW; Bandopadhayay P; Phoenix TN
Cancer Res; 2022 Sep; 82(17):2980-3001. PubMed ID: 35802025
[TBL] [Abstract][Full Text] [Related]
2. Pursuing FOXR2-Driven Oncogenesis.
Liu APY; Northcott PA
Cancer Res; 2022 Sep; 82(17):2977-2979. PubMed ID: 36052493
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of FOXR2 suppresses the tumorigenesis, growth and metastasis of prostate cancer.
Xu W; Chang J; Liu G; Du X; Li X
Biomed Pharmacother; 2017 Mar; 87():471-475. PubMed ID: 28068638
[TBL] [Abstract][Full Text] [Related]
4. FOXR2 Interacts with MYC to Promote Its Transcriptional Activities and Tumorigenesis.
Li X; Wang W; Xi Y; Gao M; Tran M; Aziz KE; Qin J; Li W; Chen J
Cell Rep; 2016 Jul; 16(2):487-497. PubMed ID: 27346356
[TBL] [Abstract][Full Text] [Related]
5. Insights into the molecular roles of FOXR2 in the pathology of primary pediatric brain tumors.
Gharbaran R
Crit Rev Oncol Hematol; 2023 Dec; 192():104188. PubMed ID: 37879492
[TBL] [Abstract][Full Text] [Related]
6. FOXR2 Promotes the Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Human Colorectal Cancer Cells.
Lu SQ; Qiu Y; Dai WJ; Zhang XY
Oncol Res; 2017 May; 25(5):681-689. PubMed ID: 28548041
[TBL] [Abstract][Full Text] [Related]
7. Forkhead-box R2 promotes metastasis and growth by stimulating angiogenesis and activating hedgehog signaling pathway in ovarian cancer.
Li B; Huang W; Cao N; Lou G
J Cell Biochem; 2018 Sep; 119(9):7780-7789. PubMed ID: 29943836
[TBL] [Abstract][Full Text] [Related]
8. Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer.
Li Y; Zu X; Hu X; Wang L; He W
Med Sci Monit; 2019 Nov; 25():8928-8939. PubMed ID: 31761897
[TBL] [Abstract][Full Text] [Related]
9. A highly active homeobox gene promoter regulated by Ets and Sp1 family members in normal granulosa cells and diverse tumor cell types.
Rao MK; Maiti S; Ananthaswamy HN; Wilkinson MF
J Biol Chem; 2002 Jul; 277(29):26036-45. PubMed ID: 11986330
[TBL] [Abstract][Full Text] [Related]
10. FOXR2 contributes to cell proliferation and malignancy in human hepatocellular carcinoma.
Wang X; He B; Gao Y; Li Y
Tumour Biol; 2016 Aug; 37(8):10459-67. PubMed ID: 26846213
[TBL] [Abstract][Full Text] [Related]
11. SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.
Cheng XH; Black M; Ustiyan V; Le T; Fulford L; Sridharan A; Medvedovic M; Kalinichenko VV; Whitsett JA; Kalin TV
PLoS Genet; 2014 Sep; 10(9):e1004656. PubMed ID: 25254494
[TBL] [Abstract][Full Text] [Related]
12. miR-202 Suppresses Cell Proliferation by Targeting FOXR2 in Endometrial Adenocarcinoma.
Deng X; Hou C; Liang Z; Wang H; Zhu L; Xu H
Dis Markers; 2017; 2017():2827435. PubMed ID: 28827892
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of FOXR2 inhibits non-small cell lung cancer cell proliferation and invasion through the Wnt/β-catenin signaling pathway.
Wang XH; Cui YX; Wang ZM; Liu J
Biochem Biophys Res Commun; 2018 Jun; 500(2):229-235. PubMed ID: 29634928
[TBL] [Abstract][Full Text] [Related]
14. ETS Factor ETV5 Activates the Mutant Telomerase Reverse Transcriptase Promoter in Thyroid Cancer.
Bullock M; Lim G; Zhu Y; Åberg H; Kurdyukov S; Clifton-Bligh R
Thyroid; 2019 Nov; 29(11):1623-1633. PubMed ID: 31452441
[No Abstract] [Full Text] [Related]
15. Foxr2 promotes formation of CNS-embryonal tumors in a Trp53-deficient background.
Poh B; Koso H; Momota H; Komori T; Suzuki Y; Yoshida N; Ino Y; Todo T; Watanabe S
Neuro Oncol; 2019 Aug; 21(8):993-1004. PubMed ID: 30976792
[TBL] [Abstract][Full Text] [Related]
16. FOXR2 Stabilizes MYCN Protein and Identifies Non-
Schmitt-Hoffner F; van Rijn S; Toprak UH; Mauermann M; Rosemann F; Heit-Mondrzyk A; Hübner JM; Camgöz A; Hartlieb S; Pfister SM; Henrich KO; Westermann F; Kool M
J Clin Oncol; 2021 Oct; 39(29):3217-3228. PubMed ID: 34110923
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic ETS Factors in Prostate Cancer.
Nicholas TR; Strittmatter BG; Hollenhorst PC
Adv Exp Med Biol; 2019; 1210():409-436. PubMed ID: 31900919
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of FOXR2 inhibits hypoxia-driven ROS-induced migration and invasion of thyroid cancer cells via regulation of the hedgehog pathway.
Liao CW; Zheng C; Wang L
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1076-1082. PubMed ID: 32068268
[TBL] [Abstract][Full Text] [Related]
19. The Relationship of FOXR2 Gene Expression Profile with Epithelial-Mesenchymal Transition Related Markers in Epithelial Ovarian Cancer.
Asadollahi S; Mazaheri MN; Karimi-Zarchi M; Fesahat ; Farzaneh
Klin Onkol; 2020; 33(3):201-207. PubMed ID: 32683876
[TBL] [Abstract][Full Text] [Related]
20. Identification of FoxR2 as an oncogene in medulloblastoma.
Koso H; Tsuhako A; Lyons E; Ward JM; Rust AG; Adams DJ; Jenkins NA; Copeland NG; Watanabe S
Cancer Res; 2014 Apr; 74(8):2351-61. PubMed ID: 24599127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
